May 7, 2021
GENEVA (AFP) – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) expressed disappointment on Wednesday at the United States’ (US) decision to support a global waiver on patent protections for COVID-19 vaccines.
“As we have consistently stated, a waiver is the simple but the wrong answer to what is a complex problem,” the lobby group said in a statement, describing the US move as “disappointing”.
“Waiving patents of COVID-19 vaccines will not increase production nor provide practical solutions needed to battle this global health crisis,” it continued.
Instead, IFPMA argued, governments should be focussing on eliminating trade barriers as well as “addressing bottlenecks in supply chains and scarcity of raw materials and ingredients” for producing COVID-19 vaccines.
Related Keywords
Geneva , Genè , Switzerland , Kadena Air Base , Japan General , Japan , South Africa , India , Thomas Cueni , Moderna Stephane Bancel , International Federation Of Pharmaceutical Manufacturers , Kadena Air , International Federation , Pharmaceutical Manufacturers , United State , ஜிநீவ , சுவிட்சர்லாந்து , கடேனா அேக அடித்தளம் , ஜப்பான் ஜநரல் , ஜப்பான் , இந்தியா , சர்வதேச கூட்டமைப்பு ஆஃப் மருந்து உற்பத்தியாளர்கள் , கடேனா அேக , சர்வதேச கூட்டமைப்பு , மருந்து உற்பத்தியாளர்கள் , ஒன்றுபட்டது நிலை ,
comparemela.com © 2020. All Rights Reserved.